Unleashing the Potential of Nrf2: A Novel Therapeutic Target for Pulmonary Vascular Remodeling

• Published in: Antioxidants Vol. 12; no. 11; p. 1978
• Main Authors: Fang, Qin, Bai, Yang, Hu, Shuiqing, Ding, Jie, Liu, Lei, Dai, Meiyan, Qiu, Jie, Wu, Lujin, Rao, Xiaoquan, Wang, Yan
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 01-11-2023
• Subjects: Antioxidants; Clinical trials; Development and progression; Drug approval; Drug development; Endothelium; Enzymes; Extracellular matrix; Genes; Kinases; Life expectancy; Lung diseases; Medical prognosis; Nitric oxide; Nrf2; Oxidative stress; Pathogenesis; Proteins; Pulmonary arteries; Pulmonary hypertension; pulmonary vascular remodeling; Smooth muscle; Therapeutic targets; Vasodilation
• ISSN: 2076-3921; 2076-3921
• DOI: 10.3390/antiox12111978

Pulmonary vascular remodeling, characterized by the thickening of all three layers of the blood vessel wall, plays a central role in the pathogenesis of pulmonary hypertension (PH). Despite the approval of several drugs for PH treatment, their long-term therapeutic effect remains unsatisfactory, as they mainly focus on vasodilation rather than addressing vascular remodeling. Therefore, there is an urgent need for novel therapeutic targets in the treatment of PH. Nuclear factor erythroid 2-related factor 2 (Nrf2) is a vital transcription factor that regulates endogenous antioxidant defense and emerges as a novel regulator of pulmonary vascular remodeling. Growing evidence has suggested an involvement of Nrf2 and its downstream transcriptional target in the process of pulmonary vascular remodeling. Pharmacologically targeting Nrf2 has demonstrated beneficial effects in various diseases, and several Nrf2 inducers are currently undergoing clinical trials. However, the exact potential and mechanism of Nrf2 as a therapeutic target in PH remain unknown. Thus, this review article aims to comprehensively explore the role and mechanism of Nrf2 in pulmonary vascular remodeling associated with PH. Additionally, we provide a summary of Nrf2 inducers that have shown therapeutic potential in addressing the underlying vascular remodeling processes in PH. Although Nrf2-related therapies hold great promise, further research is necessary before their clinical implementation can be fully realized.